genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • DO NOT REUSE
      Cell Signaling

      Amino Acid That Delivers “Slow Down” Signal to Brain May Contribute…

      Cancer
      Cancer

      Preventing Metastasis with a STING

      Artificial Intelligence

      One AI Tool Bests Another in Enzyme Prediction Match

      Cancer

      How Incurable Melanoma Resists Treatment

      Rodeo
      AgBio

      Food For Thought: Final Report from the AGBT Ag Meeting

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      Adeno-associated viruses
      Base Editing

      One-Time Treatment: Base Editing Shows Promise vs. SMA

      Drug Delivery

      Nature’s Needle: Feng Zhang’s Team Re-engineers Bacterial “Syringes” for Programmable Protein…

      Bioprocessing

      Polymer Formulation to Improve Existing Antibiotics

      Bioprocessing

      Key Consideration for Going Digital

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home Companies Page 2

Companies

  • 23andMe
  • Abbvie
  • AdnaGen
  • Agilent Technologies
  • Alexion Pharmaceuticals
  • Amgen
  • Astellas
  • AstraZeneca
  • Audentes Therapeutics
  • Berkeley Lights
  • Bio-Rad Laboratories
  • Biogen
  • Cancer Genetics
  • Catalent
  • Charles RIver Laboratories
  • Dana-Farber Cancer Institute
  • deCODE genetics
  • Dicerna
  • Dimension Therapeutics
  • Exact Sciences
  • Foundation Medicine
  • GE Healthcare
  • GeneInsight
  • Gilead Sciences
  • GlaxoSmithKline
  • Halozyme Therapeutics
  • Hitachi High-Technologies
  • Horizon Discovery Group
  • Human Longevity
  • Illumina
  • Jackson Laboratory
  • Janssen Biotech
  • LabCorp
  • Maravai LifeSciences
  • MD Anderson
  • MDxHealth
  • MedImmune
  • Memorial Sloan Kettering Cancer Center
  • Merck & Co
  • Merck KGaA
  • NanoString Technologies
  • Novartis
  • Pathology
  • PerkinElmer
  • PersonalizeDx
  • Qiagen
  • RayBiotech
  • Roche
  • Sanofi
  • shire
  • Sigma-Aldrich
  • Synthego
  • Takeda
  • Thermo Fisher Scientific
  • UCB Biosciences
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Adeno-associated viruses
    Base Editing

    One-Time Treatment: Base Editing Shows Promise vs. SMA

    Liquid Biopsies

    Illumina, Icahn Spar over Board Indemnification for Grail Purchase

    ALS

    StockWatch: FDA Panel Enables Accelerated OK for Biogen ALS Drug

    Liquid Biopsies

    StockWatch: Icahn Pursues Illumina Board Seats, and a Sell-Off of Grail

    Antibody Drug Conjugates

    StockWatch: Antitrust Fears Dampen Support for $43B Pfizer-Seagen Deal

    Whole-Genome Analysis

    At JPM, Illumina Announces African-American Sequencing Collaboration

    Oncologics

    Olema Plans Pivotal Trial for Two-Prong Breast Cancer Treatment

    Blood Disorders

    Rising Star: Vega Targets Rare Blood Disorders with Antibodies

    Antibodies

    Absci Pursues Google-Sized Ambitions in Drug Discovery, Manufacturing

    Cancer

    StockWatch: Moderna Cancer Vaccine Propels 72% Surge

    Autoimmune Disorders

    Takeda Acquires Autoimmune Candidate from Nimbus for Up to $6B

    Rare and Neglected Diseases

    Amgen to Acquire Horizon for $27.8B, Expanding Rare Disease Pipeline

    CAR T-Cells

    Kite Inks Up-to-$4B Deal to Co-Develop Arcellx Myeloma CAR T-Cell Therapy

    Lung Cancer

    StockWatch: Summit Nearly Triples on Up-to-$5B Cancer Alliance with Akeso

    artificial intelligence
    Companies

    Which Artificial Intelligence System Works Best for You?

    123...70Page 2 of 70

    Recently Featured

    Amino Acid That Delivers “Slow Down” Signal to Brain May Contribute to Major Depression

    Amino Acid That Delivers “Slow Down” Signal to Brain May Contribute to Major Depression

    Preventing Metastasis with a STING

    Preventing Metastasis with a STING

    One-Time Treatment: Base Editing Shows Promise vs. SMA

    One-Time Treatment: Base Editing Shows Promise vs. SMA

    How Incurable Melanoma Resists Treatment

    How Incurable Melanoma Resists Treatment

    Read the Digital Edition

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up